Martin Dow Limited
Senior Product Manager
Mar 2020 – Continue
- Portfolio: Gastro and Medicine- Librax (Anti-Spasmodic & Anti-Anxiety), Esomax (Anti-Ulcerant) & Dexfiber (Soluble Fiber).
- Established Librax a 658 Mio brand (MAT ~ 12/2021) with 33% growth over last year.
- Identified and opened Gynae segment for Librax by engaging gynecologists in symposia and RTDs.
- Improved the ranking of Librax from 3rd to 2nd in A03A+A03C derived market (MAT ~ 03/2021) beating Anafortan Plus.
- Established Esomax a 135 Mio. plus, brand (MAT ~ 12/2021) through continuous customer engagement. The brand has shown 45% growth over last year.
- Initiated and conducted multiple CMEs/ forums for target audience including “MDL Physicians Forum”, “Gastro Experts Meeting (GEM)” and “IBS Summit” to develop a pool of loyal prescribers for Librax and Esomax.
- Successfully launched Esomax IV.
- Regularly use research and IQVIA data to identify potential markets and interact with internal customers to launch new products/ line extension
- As part of brand strategy, continuously engage trade leadership/ team to better serve external customers.
- Conceived and launched Dexfiber (HOTC brand) in Oct 2022.
Novartis Pharmaceutical
Product Manager
Nov 2016 – Jan 2020
- Portfolio: Ortho & General Medicine- Ternelin (Muscle Relaxant), Acemed (NSAID) and Doxolin (Anti-asthma)
- Won “Brand Manager of 1st Semester 2019” award on outstanding portfolio performance.
- Moved Doxolin up in the ranking from 6th to 3rd in Doxofylline market by improving market share from 2% to 12% (MAT ~ 12/2016 to MAT ~ 09/2019).
- Regained 80% of lost business of Ternelin within 1 year of its relaunch.
- Improved Ternelin HCP coverage from 6,000 to 14,000 by launching a successful collaborative campaign with Caflam (A brand of Novartis Innovative Medicines division).
The Aga Khan University Hospital
Associate Marketing
Jan 2014 - Nov 2016
Portfolio: Cardiac services, Internal Medicine, Eye and ENT, Radiology at AKUH Main campus and Aga Khan Hospital for Women and Children, Kharadar.
- Improved brand recall by planning and executing multiple ATL, BTL and digital marketing campaigns.
- Enhanced disease awareness by conducting more than 50 health talks on radio, 4 health talks on television and more than 15 health awareness sessions / health festivals on world health days.
- Increased share of voice for different hospital services by publishing more than 20 Newspaper and magazine ads.
- Highly successful in launching services include:
- Refractive Eye Surgery
- Cosmetology Services (Botox, Fillers, Dark Circles repair and Blepharoplasty)Type 1 Diabetes and Continuous Glucose Monitoring Services
Senior Marketing Executive
Oct 2013 - Jan 2014
- Impactful contribution during ‘advertising/ digital Agency Selection Process’ and took the selected agencies onboard within 2 months.
- Strategically evaluated the business of ‘Referral Offices in Dubai, Quetta and Hyderabad’ within 6 weeks.
GlaxoSmithKline (GSK)
Product Specialist (Vaccines)
Apr 2012 - Sep 2013
- Sales Responsibility: Cervarix (HPV Vaccine) in gynae segment.
- Assigned Area: Karachi-2 (Covered approximately 70% of Karachi).
- Established Cervarix by generating prescriptions from leading gynecologists and institutes e.g., JPMC, The Aga Khan University hospital etc.
Medical Services Executive
Feb 2009 - Mar 2012
- Sales Responsibility: Velosef (Cephradine), Capoten (Captopril), FefolVit (Hematinic), Chewcal (Calcium) and Engran (Multivitamins).
- Assigned Territory: Orangi Town, Nazimabad, Hub, Winder, Uthal and Bela.
- Part of sales team which made “Velosef a Billion Brand”.
- Doubled Velosef sales in 3 years in the assigned territory, also given substantial growth on FefolVit, Chewcal and Capoten.
- Won “Master Detailer Award” in planning and strategic meeting-2009 and “Disease and Product Knowledge award” in 2012.
